Skip to main content
. 2017 Nov 27;8(66):110176–110186. doi: 10.18632/oncotarget.22701

Figure 3. Expression of wt- ERα, ERαDel.2, ERαDel.4, ERαDel.7 and ERαDel.3, 4 in human endometrium in the total sample population (n = 58 patients) without taking into account the phase of the menstrual cycle or the existence of endometriosis.

Figure 3

Data from three to six experiments are expressed on a logarithmic scale in relation to GAPDH and ß-actin mRNA levels (mean ± standard deviation). *p < 0.05, **p < 0.01 in comparison with wt-ERa.